Patients with sickle cell disease and beta-thalassemia treated with exagamglogene autotemcel reported substantial and ...

IAUI provides income and capital preservation, making it appealing for income investors seeking diversification and reduced ...

XDIV earns a buy rating for its quality, income focus, and high yield, plus key risks and how best to use it. Click here to ...

The consensus price target hints at a 38.8% upside potential for Contango ORE, Inc. (CTGO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in ...

The Federal Reserve’s September interest rate cut has triggered a shift in the corporate bond market, with spreads in both ...

Ethereum rebounds to $3,941, forming a bull flag pattern. Indicators suggest a potential rally toward $4,500 if support at $3 ...

For this exercise, we analyzed the spin rates across all nine impact points on the face—95 mph, 10.5-degree heads—to ...

The mean of analysts' price targets for Beam Therapeutics (BEAM) points to a 76.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement ...

This study offers a valuable methodological advance by introducing a gene panel selection approach that captures combinatorial specificity to define cell identity. The findings address key limitations ...

The reading slump has been well documented in other data sources. In January, results from the National Assessment of Educational Progress showed reading scores for 4th and 8th grades continuing to ...

The 3 mid-cap funds mentioned in this editorial were identified by evaluation of 5-year rolling CAGR and risk metrics such as ...

If the dismal past performance of mutual funds hadn't already convinced you of how difficult it is to beat the stock market, the market-lagging performance of U.S. college and university endowments ...